Gargi Bose*

Department of Nutrition, Ramananda College, Bishnupur, Bankura, West Bengal, India

*Corresponding Author: Gargi Bose, Department of Nutrition, Ramananda College, Bishnupur, Bankura, West Bengal, India.

Received: July 16, 2025; Published: July 26, 2025

Abstract

The number of people living with dementia and neurodegeneration is increasing by the day. It is projected to increase to an alarming level by 2050. Recent research implicates the involvement of gut-brain axis and gut dysbiosis in the development of such disorders. As lifestyle and nutritional modification assumes an integral part of palliative care for individuals with neurodegeneration probiotics present with a potential for biotherapeutic application. This short review explores the possible relationship of dysbiosis to neurodegeneration and potential for probiotic therapy.

Keywords: Neurodegeneration; Alzheimer’s Disease; Gut-brain Axis; Gut Dysbiosis; Probiotics

References

1. Twiss E., et al. “Global Diseases Deserve Global Solutions: Alzheimer’s Disease”. Neurology International. 17.6 (2025): 92.
2. Chen S., et al. “The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories”. The Lancet Global Health9 (2024): e1534-1543.
3. Padhi P., et al. “Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders”. Frontiers in Neuroscience 16 (2022).
4. Alkasir R., et al. “Human gut microbiota: the links with dementia development”. Protein Cell8 (2017): 90-102.
5. Westfall S., et al. “Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis”. Cellular and Molecular Life Sciences20 (2017): 3769-3787.
6. Martinez JE., et al. “Unhealthy lifestyle and gut dysbiosis: a better understanding of the effects of poor diet and nicotine on the intestinal microbiome”. Frontiers in Endocrinology 12 (2021): 667066.
7. Alou MT., et al. “Diet influence on the gut microbiota and dysbiosis related to nutritional disorders”. Human Microbiome Journal 1 (2016): 3-11.
8. Morshedi M., et al.“Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review”. Journal of Neuroinflammation 16 (2019): 231.
9. Kunst C., et al. “The influence of gut microbiota on oxidative stress and the immune system”. Biomedicines5 (2023): 1388.
10. Mostafavi AH and Zhou JR. “Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases”. Antioxidants13 (2024): 985.
11. Tang W., et al. “The Impact of Gut Microbiota Disorders on the Blood-Brain Barrier”. Infection and Drug Resistance13 (2020): 3351-3363.
12. Welcome MO. “Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways”. NeuroMolecular Medicine21 (2019): 205-226.
13. Guedj A., et al. “Gut microbiota shape ‘inflamm-ageing’cytokines and account for age-dependent decline in DNA damage repair”. Gut6 (2020): 1064-1075.
14. Spychala MS., et al. “Age‐related changes in the gut microbiota influence systemic inflammation and stroke outcome”. Annals of Neurology1 (2018): 23-36.
15. Mangiola F., et al. “Gut microbiota and aging”. European Review for Medical & Pharmacological Sciences21 (2018).
16. Wang L., et al. “Lactobacillus plantarumDP189 Reduces α-SYN Aggravation in MPTP-Induced Parkinson's Disease Mice via Regulating Oxidative Damage, Inflammation, and Gut Microbiota Disorder”. Journal of Agricultural and Food Chemistry4 (2022): 1163-1173.
17. Prajapati SK., et al. “Protection of Alzheimer's disease progression by a human-origin probiotics cocktail”. Scientific Reports1 (2025): 1589.
18. Dong Y., et al. “The Role of Probiotics in Modulating the Gut Microbiome in Alzheimer’s Disease: A Review”. Foods14 (2025): 1531.
19. Asghari KM., et al.“The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial”. Scientific Reports 13 (2023): 18577.
20. Basak S., and Gokhale J. "Immunity boosting nutraceuticals: Current trends and challenges". Journal of Food Biochemistry 3 (2022): e13902.
21. Simpson DSA and Oliver PL. “ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease”. Antioxidants 8 (2020): 743.
22. Zhao X., et al. “Nicotinamide mononucleotide improves the Alzheimer's disease by regulating intestinal microbiota”. Biochemical and Biophysical Research Communications 670 (2023): 27-35.
23. Yeon SW., et al. “Fermented milk of Lactobacillus helveticus IDCC3801 reduces beta-amyloid and attenuates memory deficit”. Journal of Functional Foods2 (2010): 143-52.
24. Abdelhamid M., et al. “Probiotic Bifidobacterium breve prevents memory impairment through the reduction of both amyloid-β production and microglia activation in APP knock-in mouse”. Journal of Alzheimer’s Disease4 (2022): 1555-1571.

Citation

Citation: Gargi Bose. “Probiotics in Regulation of Gut Dysbiosis – A Short Review on Potential Therapy for Alzheimer’s Disease".Acta Scientific Microbiology 8.8 (2025): 11-13.

Copyright

Copyright: © 2025 Gargi Bose. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.